Detalhe da pesquisa
1.
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.
Lancet
; 399(10324): 541-553, 2022 02 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35123694
2.
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.
N Engl J Med
; 380(24): 2317-2326, 2019 06 13.
Artigo
Inglês
| MEDLINE | ID: mdl-31189035
3.
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.
N Engl J Med
; 381(20): 1929-1939, 2019 11 14.
Artigo
Inglês
| MEDLINE | ID: mdl-31722153
4.
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study.
Gynecol Oncol
; 164(2): 428-436, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34903380
5.
Patient-reported outcome changes at the end of life in recurrent platinum-resistant ovarian cancer: An NRG oncology/GOG study.
Gynecol Oncol
; 163(2): 392-397, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34548162
6.
GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function.
Gynecol Oncol
; 160(1): 244-251, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33109392
7.
An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275.
Gynecol Oncol
; 158(2): 354-360, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32460997
8.
Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study.
Gynecol Oncol
; 156(1): 131-139, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31759774
9.
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study.
Int J Gynecol Cancer
; 30(5): 596-601, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32114513
10.
GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE).
Gynecol Oncol
; 155(3): 452-460, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31679787
11.
Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 150(1): 119-126, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29778506
12.
Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 145(1): 122-129, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28190649
13.
Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 144(3): 459-467, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28089376
14.
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
Lancet Oncol
; 16(3): 301-11, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25638326
15.
Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 139(3): 541-5, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26456812
16.
Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study.
Gynecol Oncol
; 128(3): 573-8, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23219660
17.
Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study.
Gynecol Oncol
; 125(2): 315-9, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22307062
18.
The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study.
Gynecol Oncol
; 124(3): 379-82, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22119995
19.
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial.
J Clin Oncol
; 40(9): 968-977, 2022 03 20.
Artigo
Inglês
| MEDLINE | ID: mdl-35007153
20.
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study.
J Clin Oncol
; 40(35): 4119-4128, 2022 12 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35759733